Conversion from the conventional cyclosporine formulation (sandimmune) to a new oral microemulsion (neoral) in stable liver transplant patients

By Dibo-Cohen J.M.   Conort O.   Conti F.   Bernard D.   Hazebroucq G.   Calmus Y.  

Transplantation Proceedings, Vol. 30, Iss. 5, 1998-08 ,pp. : 1857-1857

Elsevier

Access to resources Recommend Favorite

Improved Absorption and Bioavailability of Cyclosporine A From a Microemulsion Formulation in Lung Transplant Recipients Affected With Cystic Fibrosis

By Reynaud-Gaubert M.   Viard L.   Girault D.   Bertault-Perez P.   Guignard M.   Metras D.   Fuentes P.  

Transplantation Proceedings, Vol. 29, Iss. 5, 1997-08 ,pp. : 2450-2453

Elsevier

Access to resources Recommend Favorite

Tacrolimus to cyclosporine microemulsion formulation conversion in the pediatric liver transplant patient

By Falkenstein K.   Dunn S.  

Transplantation Proceedings, Vol. 30, Iss. 5, 1998-08 ,pp. : 1964-1966

Elsevier

Access to resources Recommend Favorite

Benefits of cyclosporine microemulsion (Neoral) C 2 monitoring are sustained at 1 year in de novo liver transplant recipients

By Lake J.R.   Neo-INT-06 Study Group  

Transplantation Proceedings, Vol. 33, Iss. 7, 2001-11 ,pp. : 3092-3093

Elsevier

Access to resources Recommend Favorite

Conversion from tacrolimus to microemulsion formulation of cyclosporine in pediatric liver transplantation

By Alberti D.   Reding R.   Otte J.B.   Falchetti D.   Rigamonti W.   Caccia G.   Sokal E.   de Ville de Goyet J.  

Transplantation Proceedings, Vol. 30, Iss. 5, 1998-08 ,pp. : 1858-1860

Elsevier

Access to resources Recommend Favorite